Found 70 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 1
Interventional
This study investigates the condition of relapsed/refractory myeloma. It focuses on understanding more about this condition through the use of an investigational medication.The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. It looks at how well participants tolerate the medication and its overall …
18 years - 80 years
All genders
Phase 2
Interventional
This study investigates high-risk asthma. It involves evaluating an investigational medication to understand its effects on this condition.The focus of the study is to evaluate the safety, effectiveness, and tolerability of the investigational medication in comparison to a placebo.Who can participate: Adults aged 18 to 80 years with physician-diagnosed mild-to-moderate …
18 years or above
Accepts healthy volunteer
Male
Phase 3
This study investigates the use of tadalafil for erectile dysfunction. The purpose of this study is to see if participants can choose and use tadalafil appropriately based on product labeling and a health survey.The study evaluates how well participants can follow instructions for using tadalafil safely and effectively. It looks …
10 years - 65 years
All genders
Phase 3
Interventional
This study investigates sickle-cell disease. Participants aged 10 to 65 years will be involved in this research to gather more information.The purpose of this study is to evaluate the safety and effectiveness of an investigational medication. It will help researchers understand more about this treatment option for sickle-cell disease.Who can …
12 years or above
All genders
Phase 4
Interventional
This study investigates synovial hypertrophy in individuals with hemophilia A.The study evaluates the effects of a weekly dose of investigational medication over a 12-month period. It focuses on assessing changes in joint conditions related to synovial hypertrophy.Who can participate: Participants must be 12 years or older with moderate to severe …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of different doses of an investigational medication compared to a placebo for Crohn's disease.The purpose of this study is to understand the safety and effectiveness of the investigational medication for people with Crohn's disease.Who can participate: Adults with moderate to severe Crohn's disease, who have …
18 years or above
All genders
Phase 3
Interventional
This study investigates the effects of an oral investigational medication in adults with immune thrombocytopenia (ITP) who did not respond to first-line treatment.The study evaluates the medication's safety and effectiveness in managing the condition.Who can participate: Adults aged 18 and older with a documented diagnosis of primary ITP who have …
1 year - 18 years
All genders
Phase 2
Interventional
This study investigates chronic graft versus host disease (cGVHD) in children. The purpose of this study is to evaluate an investigational medication in children who have this condition.The study will assess the safety and effectiveness of the investigational medication in treating cGVHD. Researchers will evaluate how well the medication works …
16 years - 80 years
All genders
Phase 3
Interventional
This study focuses on participants with moderately to severely active symptoms.The study evaluates the efficacy and safety of an investigational medication. It seeks to understand its potential effects on Crohn's disease.Who can participate: Participants aged 18 to 80 years, or 16 to under 18 years if meeting certain development criteria, …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates moderately to severely active Crohn's Disease. The purpose of this study is to understand how an investigational medication may help patients with this condition.The study evaluates the safety and how well the investigational medication works for people with Crohn's Disease. It looks at how patients respond to …